Our recently signed collaboration with Orion was featured in the San Diego Business Journal. We look forward to working with our new partners to create meaningful therapies for patients in the areas of oncology and pain. Two Bear Capital #oncology #pain #MMPs #EMPs #antibodydiscovery https://lnkd.in/gSMPmnSM
Abilita Therapeutics, Inc.
生物技术
San Diego，CA 2,460 位关注者
Redefining the druggable landscape for membrane protein targets
关于我们
Abilita Therapeutics is a biotechnology company focused on redefining the druggable landscape for multi-span membrane proteins, including G Protein Coupled Receptors (GPCRs), transporters and ion channels. We are building a rich pipeline of high-value assets for such targets, with the goal of becoming the leader in discovering and developing first- and best-in-class antibody therapeutics.
- 网站
-
https://abilitabio.com
Abilita Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2014
地点
-
主要
获取路线
3210 Merryfield Row
US，CA，San Diego，92121
Abilita Therapeutics, Inc.员工
动态
-
We are pleased to announce today we entered a multi-target discovery collaboration with Orion Corporation in the areas of oncology and pain. The collaboration will leverage Abilita’s EMP? technology platform to enable drug discovery on challenging GPCR and ion channel targets. Orion will have an option to license an undisclosed Abilita discovery program and may also select two additional targets. Abilita will lead all discovery efforts and upon licensing each drug candidate, Orion will lead all development and commercialization activities. The full release is available for more details. https://lnkd.in/gN6hXuib #MMPs #oncology #pain #antibody #GPCR #ionchannel Two Bear Capital
-
Despite the development of powerful computational tools and wet-lab technologies, finding robust hits continues to be a major challenge for #drugdiscovery teams. We chat with Abilita Therapeutics, Inc. to discuss how they are addressing this challenge with new, innovative search tools.
-
Abilita Therapeutics will be attending Bio International in San Diego June 3-6. Click below to send us a meeting request in the BIO partnering system!?#BIO2024 https://lnkd.in/g6ZfvzAR
-
Our CEO Mauro Mileni and VP of Research Chris Roth were recently featured in CAS to discuss their experience and perspective on pursuit of challenging membrane protein therapeutics. Abilita Therapeutics, based in San Diego, is a pioneering biotechnology company that enables the development of groundbreaking therapeutics for diseases lacking viable treatment options. Our innovative approach unlocks novel drug targets previously inaccessible, allowing us to address diseases with unmet medical needs and revolutionize patient care. #GPCRs #Ionchannels #transporters #biologics Two Bear Capital https://lnkd.in/gWecUMaG